Distinct profiles of anhedonia and reward processing and their prospective associations with quality of life among individuals with mood disorders
- PMID: 37402852
- DOI: 10.1038/s41380-023-02165-1
Distinct profiles of anhedonia and reward processing and their prospective associations with quality of life among individuals with mood disorders
Abstract
Leading professional health bodies have called for the wider adoption of Patient Reported Outcome Measures, such as quality of life, in research and clinical practice as a means for understanding why the global burden of depression continues to climb despite increased rates of treatment use. Here, we examined whether anhedonia-an often recalcitrant and impairing symptom of depression-along with its neural correlates, was associated with longitudinal changes in patient-reported quality of life among individuals seeking treatment for mood disorders. We recruited 112 participants, including n = 80 individuals with mood disorders (58 unipolar, 22 bipolar) and n = 32 healthy controls (63.4% female). We assessed anhedonia severity along with two electroencephalographic markers of neural reward responsiveness (scalp-level 'Reward Positivity' amplitude and source-localized reward-related activation in the dorsal anterior cingulate cortex), and assessed quality of life at baseline, 3- and 6-month follow-up. Anhedonia emerged as a robust correlate of quality of life cross-sectionally and longitudinally among individuals with mood disorders. Furthermore, increased neural reward responsiveness at baseline was associated with greater improvements in quality of life over time, and this improvement was mediated by longitudinal improvements in anhedonia severity. Finally, differences in quality of life observed between individuals with unipolar and bipolar mood disorders were mediated by differences in anhedonia severity. Our findings indicate that anhedonia and its reward-related neural correlates are linked to variability in quality of life over time in individuals with mood disorders. Treatments capable of improving anhedonia and normalizing brain reward function may be necessary for improving broader health outcomes for individuals seeking treatment for depression.ClinicalTrials.gov identifier: NCT01976975.
© 2023. The Author(s), under exclusive licence to Springer Nature Limited.
Similar articles
-
Pramipexole in addition to mood stabilisers for treatment-resistant bipolar depression: the PAX-BD randomised double-blind placebo-controlled trial.Health Technol Assess. 2025 May;29(21):1-216. doi: 10.3310/HBFC1953. Health Technol Assess. 2025. PMID: 40455248 Free PMC article. Clinical Trial.
-
Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults.Cochrane Database Syst Rev. 2015 Sep 29;(9):CD011611. doi: 10.1002/14651858.CD011611.pub2. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2021 Oct 8;10:CD011611. doi: 10.1002/14651858.CD011611.pub3. PMID: 26415966 Updated.
-
Reward function as an outcome predictor in youth with mood and anxiety symptoms.J Affect Disord. 2021 Jan 1;278:433-442. doi: 10.1016/j.jad.2020.09.074. Epub 2020 Sep 18. J Affect Disord. 2021. PMID: 33010568 Free PMC article.
-
Acupuncture for depression.Cochrane Database Syst Rev. 2018 Mar 4;3(3):CD004046. doi: 10.1002/14651858.CD004046.pub4. Cochrane Database Syst Rev. 2018. PMID: 29502347 Free PMC article.
-
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948. Health Technol Assess. 2024. PMID: 39367772 Free PMC article.
Cited by
-
Hedonic capacity in a Chinese community population sample: psychometric properties of the dimensional anhedonia rating scale (DARS) and exploration of gender differences.BMC Psychol. 2025 Apr 21;13(1):410. doi: 10.1186/s40359-025-02740-x. BMC Psychol. 2025. PMID: 40259365 Free PMC article.
-
Trajectories of Anhedonia Symptoms after Traumatic Injury.Eur J Trauma Dissociation. 2024 Jun;8(2):100408. doi: 10.1016/j.ejtd.2024.100408. Epub 2024 Apr 25. Eur J Trauma Dissociation. 2024. PMID: 38799039 Free PMC article.
-
Brain-based graph-theoretical predictive modeling to map the trajectory of anhedonia, impulsivity, and hypomania from the human functional connectome.Neuropsychopharmacology. 2024 Jun;49(7):1162-1170. doi: 10.1038/s41386-024-01842-1. Epub 2024 Mar 13. Neuropsychopharmacology. 2024. PMID: 38480910 Free PMC article.
-
Cognitive Signatures of Depressive and Anhedonic Symptoms and Affective States Using Computational Modeling and Neurocognitive Testing.Biol Psychiatry Cogn Neurosci Neuroimaging. 2024 Jul;9(7):726-736. doi: 10.1016/j.bpsc.2024.02.005. Epub 2024 Feb 23. Biol Psychiatry Cogn Neurosci Neuroimaging. 2024. PMID: 38401881 Free PMC article.
-
Smoking Progression and Nicotine-Enhanced Reward Sensitivity Predicted by Resting-State Functional Connectivity in Salience and Executive Control Networks.Nicotine Tob Res. 2024 Sep 23;26(10):1305-1312. doi: 10.1093/ntr/ntae084. Nicotine Tob Res. 2024. PMID: 38624067 Free PMC article.
References
-
- James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789–858. - DOI
-
- Kraus C, Kadriu B, Lanzenberger R, Zarate CA, Kasper S. Prognosis and improved outcomes in major depression: a review. Transl Psychiatry. 2019;9:1–17. - DOI
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical